Shift of target organs in cycasin carcinogenesis.
D000232:Adenofibroma / Q000139:chemically induced; D000284:Administration, Oral; D000818:Animals; D001391:Azo Compounds; D002273:Carcinogens / Q000008:administration & dosage; D005260:Female; D005947:Glucose; D006027:Glycosides; D007414:Intestinal Neoplasms / Q000139:chemically induced; D007422:Intestines / Q000473:pathology; D007680:Kidney Neoplasms / Q000139:chemically induced; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D000432:Methanol; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D009928:Organ Specificity; D051381:Rats; D013736:Testicular Neoplasms / Q000139:chemically induced; D013737:Testis / Q000473:pathology
D001391:Azo Compounds; D002273:Carcinogens; D006027:Glycosides; D005947:Glucose; D000432:Methanol